Ketogenic diet protects MPTP‐induced mouse model of Parkinson's disease via altering gut microbiota and metabolites

Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease

Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622 · see citing works

Gut microbiota are related to Parkinson's disease and clinical phenotype

Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968 · see citing works

The epidemiology of Parkinson's disease: risk factors and prevention

Ascherio, A., & Schwarzschild, M. A. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30230-7 · Cited by 1,837 · see citing works

The Genus Alistipes: Gut Bacteria With Emerging Implications to Inflammation, Cancer, and Mental Health

Parker, B. J., Wearsch, P. A., Veloo, A. C. M., & Rodriguez‐Palacios, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00906 · Cited by 1,732 · see citing works

Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology

Simon, D. K., Tanner, C. M., & Brundin, P. (2020) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2019.08.002 · Cited by 1,114 · see citing works

The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet

Olson, C. A., Vuong, H. E., Yano, J. M., Liang, Q. Y., Nusbaum, D. J., & Hsiao, E. Y. (2018) · Cell · doi:10.1016/j.cell.2018.04.027 · Cited by 1,057 · see citing works

The gut microbiota at the intersection of diet and human health

Gentile, C. L., & Weir, T. L. (2018) · Science · doi:10.1126/science.aau5812 · Cited by 1,049 · see citing works

Microbiota-modulated metabolites shape the intestinal microenvironment by regulating NLRP6 inflammasome signaling

Levy, M., Thaiss, C. A., Zeevi, D., Dohnalová, L., Zilberman-Schapira, G., Mahdi, J. A., David, E., Savidor, A., Korem, T., Herzig, Y., et al. (2015) · Cell · doi:10.1016/j.cell.2015.10.048 · Cited by 960 · see citing works

Microbiota-Brain-Gut Axis and Neurodegenerative Diseases

Quigley, E. M. M. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0802-6 · Cited by 804 · see citing works

Global Trends in the Incidence, Prevalence, and Years Lived With Disability of Parkinson's Disease in 204 Countries/Territories From 1990 to 2019

Ou, Z., Pan, J., Tang, S., Duan, D., Yu, D., Nong, H., & Wang, Z. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.776847 · Cited by 739 · see citing works

Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation

Romano, S., Savva, G. M., Bedarf, J. R., Charles, I. G., Hildebrand, F., & Narbad, A. (2021) · npj Parkinson's Disease · doi:10.1038/s41531-021-00156-z · Cited by 707 · see citing works

Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment

Nagpal, R., Neth, B. J., Wang, S., Craft, S., & Yadav, H. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.08.032 · Cited by 653 · see citing works

Fecal microbiota transplantation protects rotenone-induced Parkinson’s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis

Zhao, Z., Ning, J., Bao, X.-Q., Shang, M., Ma, J., Li, G., & Zhang, D. (2021) · Microbiome · doi:10.1186/s40168-021-01107-9 · Cited by 616 · see citing works

Mouse Microbiota Models: Comparing Germ-Free Mice and Antibiotics Treatment as Tools for Modifying Gut Bacteria

Kennedy, E. A., King, K. Y., & Baldridge, M. T. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01534 · Cited by 602 · see citing works

Brain-Gut-Microbiota Axis in Parkinson’s Disease

Mulak, A. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i37.10609 · Cited by 583 · see citing works

Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade

Ferrere, G., Tidjani Alou, M., Liu, P., Goubet, A.-G., Fidelle, M., Kepp, O., Durand, S., Iebba, V., Fluckiger, A., Daillère, R., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.145207 · Cited by 533 · see citing works

D-β-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease

Tieu, K., Perier, C., Caspersen, C., Teismann, P., Wu, D.-C., Yan, S.-D., Naini, A., Vila, M., Jackson-Lewis, V., Ramasamy, R., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318797 · Cited by 497 · see citing works

Ketogenic Diet Reduces Midlife Mortality and Improves Memory in Aging Mice

Newman, J. C., Covarrubias, A. J., Zhao, M., Yu, X., Gut, P., Ng, C.-P., Huang, Y., Haldar, S., & Verdin, E. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.08.004 · Cited by 493 · see citing works

Analysis of Gut Microbiota in Patients with Parkinson’s Disease

Petrov, V. A., Saltykova, I. V., Zhukova, I. A., Alifirova, V. M., Zhukova, N. G., Dorofeeva, Y. B., Tyakht, A. V., Kovarsky, B. A., Alekseev, D. G., Kostryukova, E. S., et al. (2017) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-017-3700-7 · Cited by 487 · see citing works

FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial

McIntosh, K., Reed, D. E., Schneider, T., Dang, F., Keshteli, A. H., Palma, G. D., Madsen, K. L., Berčík, P., & Vanner, S. J. (2016) · Gut · doi:10.1136/gutjnl-2015-311339 · Cited by 480 · see citing works

Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease

Lin, C.-H., Chen, C.-C., Chiang, H.-L., Liou, J.-M., Chang, C.-M., Lu, T.-P., Chuang, E. Y., Tai, Y.-C., Cheng, C., Lin, H.-Y., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1528-y · Cited by 469 · see citing works

Dysbiosis of gut microbiota and microbial metabolites in Parkinson's disease

Sun, M.-F., & Shen, Y.-Q. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.04.004 · Cited by 445 · see citing works

Historical Perspective: Models of Parkinson’s Disease

Chia, S. J., Tan, E., & Chao, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072464 · Cited by 410 · see citing works

Role of Microbiota-Gut-Brain Axis in Regulating Dopaminergic Signaling

Hamamah, S., Aghazarian, A., Nazaryan, A., Hajnal, A. S., & Covașă, M. (2022) · Biomedicines · doi:10.3390/biomedicines10020436 · Cited by 316 · see citing works

Low-fat versus ketogenic diet in Parkinson's disease: A pilot randomized controlled trial

Phillips, M. C. L., Murtagh, D. K. J., Gilbertson, L. J., Asztely, F. J. S., & Lynch, C. D. P. (2018) · Movement Disorders · doi:10.1002/mds.27390 · Cited by 292 · see citing works

Neurotoxin-Induced Animal Models of Parkinson Disease: Pathogenic Mechanism and Assessment

Zeng, X., Geng, W.-S., & Jia, J. (2018) · ASN NEURO · doi:10.1177/1759091418777438 · Cited by 277 · see citing works

Anti-inflammatory effects of BHBA in both in vivo and in vitro Parkinson’s disease models are mediated by GPR109A-dependent mechanisms

Fu, S., Wang, J., Xue, W.-J., Liu, H., Liu, B.-R., Zeng, Y., Li, S., Huang, B., Lv, Q.-K., Wang, W., et al. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0230-3 · Cited by 269 · see citing works

Faecal microbiota transplant from aged donor mice affects spatial learning and memory via modulating hippocampal synaptic plasticity- and neurotransmission-related proteins in young recipients

D’Amato, A., Di Cesare Mannelli, L., Lucarini, E., Man, A. L., Le Gall, G., Branca, J. J. V., Ghelardini, C., Amedei, A., Bertelli, E., Regoli, M., et al. (2020) · Microbiome · doi:10.1186/s40168-020-00914-w · Cited by 269 · see citing works

Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease

Chen, S.-J., Chen, C.-C., Liao, H.-Y., Lin, Y.-T., Wu, Y.-W., Liou, J.-M., Wu, M.-S., Kuo, C.-H., & Lin, C.-H. (2022) · Neurology · doi:10.1212/wnl.0000000000013225 · Cited by 269 · see citing works

Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson’s disease via gut microbiota-GLP-1 pathway

Sun, J., Li, H., Jin, Y., Yu, J., Mao, S., Su, K.-P., Ling, Z., & Liu, J. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.10.014 · Cited by 264 · see citing works

Neuroprotective actions of sex steroids in Parkinson’s disease

Bourque, M., Dluzen, D. E., & Paolo, T. D. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.04.014 · Cited by 239 · see citing works

Intestinal Flora Modulates Blood Pressure by Regulating the Synthesis of Intestinal-Derived Corticosterone in High Salt-Induced Hypertension

Yan, X., Jin, J., Su, X., Yin, X., Gao, J., Wang, X., Zhang, S., Bu, P., Wang, M., Zhang, Y., et al. (2020) · Circulation Research · doi:10.1161/circresaha.119.316394 · Cited by 235 · see citing works

MPTP-induced mouse model of Parkinson’s disease: A promising direction of therapeutic strategies

Mustapha, M., & Taib, C. N. M. (2020) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2020.5181 · Cited by 229 · see citing works

Desulfovibrio Bacteria Are Associated With Parkinson’s Disease

Murros, K. E., Huynh, V. A., Takala, T. M., & Saris, P. E. J. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.652617 · Cited by 218 · see citing works

Advancement in the modelling and therapeutics of Parkinson’s disease

Nand, S., & Singh, P. (2020) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2020.101752 · Cited by 213 · see citing works

Neuroprotection of fasting mimicking diet on MPTP-induced Parkinson's disease mice via gut microbiota and metabolites

Zhou, Z.-L., Jia, X.-B., Sun, M.-F., Zhu, Y.-L., Qiao, C.-M., Zhang, B.-P., Zhao, L.-P., Yang, Q., Cui, C., Chen, X., et al. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00719-2 · Cited by 195 · see citing works

Sex differences in Parkinson’s disease: Features on clinical symptoms, treatment outcome, sexual hormones and genetics

Jurado-Coronel, J. C., Cabezas, R., Ávila Rodríguez, M. F., Echeverria, V., García-Segura, L. M., & Barreto, G. E. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.09.002 · Cited by 180 · see citing works

Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors

Ferrada, C., Moreno, E., Casadó, V., Bongers, G., Cortés, A., Mallol, J., Canela, E. I., Leurs, R., Ferré, S., Lluı́s, C., et al. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00152.x · Cited by 162 · see citing works

Neuroprotective and Anti-inflammatory Activities of Ketogenic Diet on MPTP-induced Neurotoxicity

Yang, X., & Cheng, B. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9336-y · Cited by 159 · see citing works

Parkinson’s Disease and Gut Microbiota

Hirayama, M., & Ohno, K. (2021) · Annals of Nutrition and Metabolism · doi:10.1159/000518147 · Cited by 158 · see citing works

Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4/MyD88/NF-κB pathway through microbiota–gut–brain axis

Zhao, Z., Li, F., Ning, J., Peng, R., Shang, J., Liu, H., Shang, M., Bao, X.-Q., & Zhang, D. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.020 · Cited by 137 · see citing works

Mucuna pruriens in Parkinson’s and in some other diseases: recent advancement and future prospective

Nand, S., Chaturvedi, V. K., Singh, P., Singh, S. P., & Singh, M. P. (2020) · 3 Biotech · doi:10.1007/s13205-020-02532-7 · Cited by 136 · see citing works

Gut microbiome in Parkinson's disease: New insights from meta-analysis

Toh, T. S., Chong, C. W., Lim, S., Bowman, J. S., Cirstea, M. S., Lin, C., Chen, C., Appel‐Cresswell, S., Finlay, B. B., & Tan, A. H. (2021) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2021.11.017 · Cited by 133 · see citing works

Dihydroquercetin supplement alleviates colonic inflammation potentially through improved gut microbiota community in mice

Wan, F., Han, H. L., Zhong, R., Wang, M., Tang, S., Zhang, S., Hou, F., Yi, B., & Zhang, H. (2021) · Food & Function · doi:10.1039/d1fo01422f · Cited by 132 · see citing works

D‐Aspartic acid is a novel endogenous neurotransmitter

D’Aniello, S., Somorjai, I., García‐Fernàndez, J., Topo, E., & D’Aniello, A. (2010) · The FASEB Journal · doi:10.1096/fj.10-168492 · Cited by 127 · see citing works

The Ketogenic Diet for Obesity and Diabetes—Enthusiasm Outpaces Evidence

Joshi, S., Ostfeld, R. J., & McMacken, M. M. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.2633 · Cited by 125 · see citing works

Alterations in the gut microbiota contribute to cognitive impairment induced by the ketogenic diet and hypoxia

Olson, C. A., Iñiguez, A. J., Yang, G. E., Fang, P., Pronovost, G. N., Jameson, K. G., Rendon, T. K., Paramo, J., Barlow, J. T., Ismagilov, R. F., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.07.004 · Cited by 125 · see citing works

Effects of different feeding regimes on muscle metabolism and its association with meat quality of Tibetan sheep

Zhang, X., Han, L., Hou, S., Raza, S. H. A., Wang, Z., Yang, B., Sun, S., Ding, B., Gui, L., Simal‐Gándara, J., et al. (2021) · Food Chemistry · doi:10.1016/j.foodchem.2021.131611 · Cited by 124 · see citing works

A metabolic profile of polyamines in parkinson disease: A promising biomarker

Saiki, S., Sasazawa, Y., Fujimaki, M., Kamagata, K., Kaga, N., Taka, H., Li, Y., Souma, S., Hatano, T., Imamichi, Y., et al. (2019) · Annals of Neurology · doi:10.1002/ana.25516 · Cited by 123 · see citing works

Histamine induces microglia activation and dopaminergic neuronal toxicity via H1 receptor activation

Rocha, S. M., Saraiva, T., Cristóvão, A. C., Ferreira, R., Santos, T., Esteves, M., Saraiva, C., Je, G., Cortes, L., Valero, J., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0600-0 · Cited by 117 · see citing works

Hydrogen Sulfide Produced by Gut Bacteria May Induce Parkinson’s Disease

Murros, K. E. (2022) · Cells · doi:10.3390/cells11060978 · Cited by 110 · see citing works

Effects of Ketogenic Diet on Neuroinflammation in Neurodegenerative Diseases

Jiang, Z., Yin, X., Wang, M., Chen, T., Wang, Y., Gao, Z., & Wang, Z. (2022) · Aging and Disease · doi:10.14336/ad.2021.1217 · Cited by 109 · see citing works

Promising drug targets and associated therapeutic interventions in Parkinson’s disease

Rai, S. N., Singh, P., Varshney, R., Chaturvedi, V. K., Vamanu, E., Singh, M. P., & Singh, S. P. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.306066 · Cited by 107 · see citing works

Therapeutic Potential of Vital Transcription Factors in Alzheimer’s and Parkinson’s Disease With Particular Emphasis on Transcription Factor EB Mediated Autophagy

Nand, S., Tiwari, N. K., Singh, P., Mishra, D., Singh, A. K., Hooshmandi, E., Vamanu, E., & Singh, M. P. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.777347 · Cited by 95 · see citing works

MPTP-induced mouse model of Parkinson’s disease: a promising direction for therapeutic strategies

Mustapha, M., & Taib, C. N. M. (2021) · Universiti Putra Malaysia Institutional Repository (Universiti Putra Malaysia) · Cited by 95 · see citing works

Exploring the microbiota-Alzheimer’s disease linkage using short-term antibiotic treatment followed by fecal microbiota transplantation

Wang, M., Cao, J., Gong, C., Amakye, W. K., Yao, M., & Ren, J. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.06.003 · Cited by 90 · see citing works

Can dietary patterns prevent cognitive impairment and reduce Alzheimer's disease risk: Exploring the underlying mechanisms of effects

Chu, C., Yu, L., Qi, G., Mi, Y., Wu, W., Lee, Y. K., Zhai, Q., Tian, F., & Chen, W. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104556 · Cited by 85 · see citing works

Histamine and the striatum

Bolam, J. P., & Ellender, T. J. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.08.013 · Cited by 83 · see citing works

Antibiotic-Induced Microbiome Depletion Protects against MPTP-Induced Dopaminergic Neurotoxicity in the Brain

Pu, Y., Chang, L., Qu, Y., Wang, S., Zhang, K., & Hashimoto, K. (2019) · Aging · doi:10.18632/aging.102221 · Cited by 80 · see citing works

Ketogenic diets improve behaviors associated with autism spectrum disorder in a sex-specific manner in the EL mouse

Ruskin, D. N., Fortin, J. A., Bisnauth, S. N., & Masino, S. A. (2016) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.10.023 · Cited by 77 · see citing works

Exploring the Paradox of COVID‐19 in Neurological Complications with Emphasis on Parkinson’s and Alzheimer’s Disease

Nand, S., Tiwari, N. K., Singh, P., Singh, S. P., Mishra, D., Imran, M., Singh, S., Hooshmandi, E., Vamanu, E., Singh, S. K., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3012778 · Cited by 66 · see citing works

Host-associated niche metabolism controls enteric infection through fine-tuning the regulation of type 3 secretion

Connolly, J. P. R., Slater, S. L., O’Boyle, N., Goldstone, R. J., Crepin, V. F., Ruano‐Gallego, D., Herzyk, P., Smith, D. G., Douce, G. R., Frankel, G. M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06701-4 · Cited by 63 · see citing works

β-Hydroxybutyrate alleviates pyroptosis in MPP+/MPTP-induced Parkinson’s disease models via inhibiting STAT3/NLRP3/GSDMD pathway

Jiang, Z., Yin, X., Wang, M., Wang, Y., Li, F., Gao, Y., Han, G., Gao, Z., & Wang, Z. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109451 · Cited by 61 · see citing works

Age- and sex-differences in the nitric oxide synthase expression and dopamine concentration in the murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Joniec‐Maciejak, I., Ciesielska, A., Kurkowska‐Jastrzębska, I., Przybyłkowski, A. M., Członkowska, A., & Członkowski, A. (2009) · Brain Research · doi:10.1016/j.brainres.2008.12.081 · Cited by 58 · see citing works

A review on preventive role of ketogenic diet (KD) in CNS disorders from the gut microbiota perspective

Rawat, K., Singh, N., Kumari, P., & Saha, L. (2020) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0078 · Cited by 58 · see citing works

Linarin ameliorates dextran sulfate sodium-induced colitis in C57BL/6J mice via the improvement of intestinal barrier, suppression of inflammatory responses and modulation of gut microbiota

Jin, C., Liu, J., Jin, R., Yao, Y., He, S., Lei, M., & Peng, X. (2022) · Food & Function · doi:10.1039/d2fo02128e · Cited by 53 · see citing works

Deciphering the gut microbiome in neurodegenerative diseases and metagenomic approaches for characterization of gut microbes

Singh, N., Singh, V., Nand, S., Mishra, V., Vamanu, E., & Singh, M. P. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113958 · Cited by 52 · see citing works

Metabolomic Modeling To Monitor Host Responsiveness to Gut Microbiota Manipulation in the BTBR T+tf/j Mouse

Klein, M. S., Newell, C., Bomhof, M. R., Reimer, R. A., Hittel, D. S., Rho, J. M., Vogel, H. J., & Shearer, J. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b01025 · Cited by 51 · see citing works

Ketogenic diets: An historical antiepileptic therapy with promising potentialities for the aging brain

Balietti, M., Casoli, T., Stefano, G. D., Giorgetti, B., Aicardi, G., & Fattoretti, P. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.02.003 · Cited by 50 · see citing works

1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Induced Parkinson’s Disease in Mouse: Potential Association between Neurotransmitter Disturbance and Gut Microbiota Dysbiosis

Zhu, Y., Huan, F., Wang, J., Xie, X., Yu, G., Wang, X., Jiang, L., Gao, R., Xiao, H., Ding, H., et al. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00475 · Cited by 48 · see citing works

Effect of ketogenic diet versus regular diet on voice quality of patients with Parkinson’s disease

Koyuncu, H., Fidan, V., Toktaş, H. E., Binay, O., & Çelik, H. (2020) · Acta Neurologica Belgica · doi:10.1007/s13760-020-01486-0 · Cited by 45 · see citing works

A new ketogenic formulation improves functional outcome and reduces tissue loss following traumatic brain injury in adult mice

Thau‐Zuchman, O., Svendsen, L., Dyall, S. C., Paredes, U. M., Rhodes, M., Priestley, J. V., Feichtinger, R. G., Kofler, B., Lotstra, S., Verkuyl, J. M., et al. (2020) · Theranostics · doi:10.7150/thno.48995 · Cited by 45 · see citing works

Korean red ginseng suppresses 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced inflammation in the substantia nigra and colon

Jeon, H., Bae, C., Lee, Y., Kim, H.-Y., & Kim, S. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.02.028 · Cited by 43 · see citing works

A Ketone Ester Drink Enhances Endurance Exercise Performance in Parkinson’s Disease

Norwitz, N. G., Dearlove, D., Lü, M., Clarke, K., Dawes, H., & Hu, M. T. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.584130 · Cited by 39 · see citing works

Early Motor-Behavioral Outcome of Ischemic Stroke with Ketogenic Diet Preconditioning: Interventional Animal Study

Shaafi, S., Sharifi‐Bonab, M., Ghaemian, N., Mokhtarkhani, M., & Akbari, H. (2019) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2018.12.024 · Cited by 36 · see citing works

Octanoic acid prevents reduction of striatal dopamine in the MPTP mouse model of Parkinson’s disease

Joniec‐Maciejak, I., Wawer, A., Turzyńska, D., Sobolewska, A., Maciejak, P., Szyndler, J., Mirowska-Guzel, D. M., & Płaźnik, A. (2018) · Pharmacological Reports · doi:10.1016/j.pharep.2018.04.008 · Cited by 34 · see citing works

Ketogenic Diet Modulates Neuroinflammation via Metabolites from Lactobacillus reuteri After Repetitive Mild Traumatic Brain Injury in Adolescent Mice

Dilimulati, D., Zhang, F., Shao, S., Lv, T., Lu, Q., Cao, M., Jin, Y., Feng, J., & Zhang, X. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01226-3 · Cited by 26 · see citing works

Effect of sex and gonadectomy on brain MPTP toxicity and response to dutasteride treatment in mice

Isenbrandt, A., Morissette, M., Bourque, M., Lamontagne‐Proulx, J., Coulombe, K., Soulet, D., & Paolo, T. D. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108784 · Cited by 23 · see citing works

Ketogenic diet-induced extension of longevity in epileptic Kcna1-null mice is influenced by gender and age at treatment onset

Chun, K., Ma, S., Oh, H., Rho, J. M., & ‍Kim, D. Y. (2017) · Epilepsy Research · doi:10.1016/j.eplepsyres.2017.11.005 · Cited by 18 · see citing works

Ketogenic diet: Predictors of seizure control

Agarwal, N., Arkilo, D., Farooq, O., Gillogly, C., Kavak, K. S., & Weinstock, A. (2017) · SAGE Open Medicine · doi:10.1177/2050312117712887 · Cited by 15 · see citing works

H2-receptors mediate histamine-induced variations in the permeability of the blood-brain barrier of rats.

Sb, B., Ward, S. M., & Robinson, A. (1992) · PubMed · Cited by 14 · see citing works

Integrative Analysis of Vaginal Microorganisms and Serum Metabolomics in Rats With Estrous Cycle Disorder Induced by Long-Term Heat Exposure Based on 16S rDNA Gene Sequencing and LC/MS-Based Metabolomics

An, G., Zhang, Y., Fan, L., Chen, J., Wei, M., Li, C., Chen, X., Li, Z., Yang, D., & Wang, J. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.595716 · Cited by 11 · see citing works

Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases

Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193 · see citing works

Diets intervene osteoporosis via gut-bone axis

Zhang, Y., Song, P., Wang, S., Liu, H., Shi, Z., & Su, J. (2024) · Gut Microbes · doi:10.1080/19490976.2023.2295432 · Cited by 180 · see citing works

Molecular Mechanisms of Neuroprotection by Ketone Bodies and Ketogenic Diet in Cerebral Ischemia and Neurodegenerative Diseases

Jang, J., Kim, S. R., Lee, J. E., Lee, S.-Y., Son, H. J., Choe, W., Yoon, K., Kim, S. S., Yeo, E., & Kang, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010124 · Cited by 107 · see citing works

The gut microbiota–brain axis in neurological disorders

You, M., Chen, N., Yang, Y., Cheng, L., He, H., Cai, Y., Liu, Y., Liu, H., & Hong, G. (2024) · MedComm · doi:10.1002/mco2.656 · Cited by 107 · see citing works

Energy Metabolism and Brain Aging: Strategies to Delay Neuronal Degeneration

Na, D., Zhang, Z., Meng, M., Li, M., Gao, J., Kong, J., Zhang, G., & Guo, Y. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01555-z · Cited by 42 · see citing works

Role of dietary fiber and short-chain fatty acids in preventing neurodegenerative diseases through the gut-brain axis

Choe, U. (2025) · Journal of Functional Foods · doi:10.1016/j.jff.2025.106870 · Cited by 45 · see citing works

Impact of the Ketogenic Diet on Neurological Diseases: A Review

Rubio, C., López-Landa, A., Parra, H. R., & Rubio‐Osornio, M. (2025) · Life · doi:10.3390/life15010071 · Cited by 30 · see citing works

Therapeutic potential of the ketogenic diet: A metabolic switch with implications for neurological disorders, the gut-brain axis, and cardiovascular diseases

Shahpasand, S., Khatami, S. H., Ehtiati, S., Alehossein, P., Salmani, F., Toutounchi, A. H., Zarei, T., Shahmohammadi, M. R., Khodarahmi‬, R., Aghamollaii, V., et al. (2024) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2024.109693 · Cited by 29 · see citing works

Unraveling the gut-brain axis: the impact of steroid hormones and nutrition on Parkinson’s disease

Neufeld, P. M., Nettersheim, R., Matschke, V., Vorgerd, M., Stahlke, S., & Theiß, C. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.391304 · Cited by 21 · see citing works

Sodium-dependent glucose co-transporter-2 inhibitor empagliflozin exerts neuroprotective effects in rotenone-induced Parkinson’s disease model in zebrafish; mechanism involving ketogenesis and autophagy

Ünal, İ., Cansız, D., Beler, M., Sezer, Z., Güzel, E., & Emekli‐Alturfan, E. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148536 · Cited by 17 · see citing works

Parkinson’s disease and the gut-brain connection: unveiling pathways, mechanisms and promising therapies

Hajare, S., & Kulkarni, Y. A. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149975 · Cited by 16 · see citing works

Investigating the Interplay between Cardiovascular and Neurodegenerative Disease

Cousineau, J., Dawe, A. M., & Alpaugh, M. (2024) · Biology · doi:10.3390/biology13100764 · Cited by 15 · see citing works

The role of gut microbiota–mitochondria crosstalk in neurodegeneration: Underlying mechanisms and potential therapies

Ju, T., Zhang, Y., Liu, L., Zhao, X., Li, X., Liu, C., Sun, S., & Wu, L. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01419 · Cited by 16 · see citing works

Clostridium butyricum Alleviates DEHP Plasticizer-Induced Learning and Memory Impairment in Mice via Gut–Brain Axis

Wang, J., Qiu, F., Zhang, Z., Liu, Y., Zhou, Q., Dai, S., Xiang, S., & Wei, C. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c03533 · Cited by 14 · see citing works

The Role of Livestock Antibiotic Use in Microbiota Dysbiosis and Neuroinflammation

Silvestro, S., Biondo, C., Midiri, A., Lucia, B. P. A., & Mancuso, G. (2025) · Antibiotics · doi:10.3390/antibiotics14060608 · Cited by 13 · see citing works

The role of microbiota dysbiosis in Parkinson’s disease: Pathophysiology and therapeutic opportunities

Santos, S., Salinas, I., Almeida, N., & Caicedo, A. (2025) · Engineering Microbiology · doi:10.1016/j.engmic.2025.100222 · Cited by 13 · see citing works

A review of the pathogenesis of epilepsy based on the microbiota-gut-brain-axis theory

Yang, W., Cui, H., Wang, C., Wang, X., Yan, C., & Cheng, W. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1454780 · Cited by 12 · see citing works

Ketogenic Metabolism in Neurodegenerative Diseases: Mechanisms of Action and Therapeutic Potential

Pawłowska, M., Kruszka, J., Porzych, M., Garbarek, J., & Nuszkiewicz, J. (2025) · Metabolites · doi:10.3390/metabo15080508 · Cited by 13 · see citing works

Gut-directed therapy in Parkinson’s disease

Benvenuti, L., Salvo, C. D., Bellini, G., Seguella, L., Rettura, F., Esposito, G., Antonioli, L., Ceravolo, R., Bernardini, N., Pellegrini, C., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1407925 · Cited by 13 · see citing works

Gut microbiota and Parkinson’s disease: exploring pathogenesis and potential therapeutic strategies from a gut-brain axis perspective

Jin, X., Wei, J., Min, X., Fan, Y., Yuan, Z., Du, Z., Su, Z., Xun, T., Du, Q., Liang, T., et al. (2025) · iScience · doi:10.1016/j.isci.2025.114185 · Cited by 10 · see citing works

The Interplay between the Gut and Ketogenic Diets in Health and Disease

Mu, C., Rho, J. M., & Shearer, J. (2025) · Advanced Science · doi:10.1002/advs.202504249 · Cited by 11 · see citing works

Unrevealing the molecular mechanisms of MPTP-induced Parkinson’s in experimental animals

Mondal, S., & Firdous, S. M. (2025) · Medicinal Chemistry Research · doi:10.1007/s00044-025-03409-1 · Cited by 9 · see citing works

The ketogenic diet in Parkinson’s disease: a potential therapeutic strategy

Pokora, B., Pokora, K., Binienda, A., & Fichna, J. (2025) · Pharmacological Reports · doi:10.1007/s43440-025-00799-2 · Cited by 9 · see citing works

Trends and hotspots on the relationship between gut microbiota and Parkinson’s Disease: a bibliometric analysis

Li, X., Hao, X., Chen, C., Zhai, C., Pan, T., Zhou, X., Liu, Y., Wu, D., & Chen, X. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1421270 · Cited by 5 · see citing works

A mixed methods feasibility study of a ketogenic diet as treatment for Parkinson’s disease

Worster, K., Colgan, D. D., Vita, A. A., McClure, C., Buttolph, L., Hodges, R., Senders, A., Erlandsen, A., Elbarbry, F., & Zwickey, H. L. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1601446 · Cited by 4 · see citing works

Chronic high-salt diet induces cognitive impairment and anxiety through gut microbiota alterations

Xu, W., Zhang, C., Bai, Y., Zhang, H., Wei, Y., Ge, Q., Guo, Y., Li, M., An, C., Chen, X., et al. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178350 · Cited by 4 · see citing works

From dysbiosis to dysfunction: specific gut microbes and metabolites in the pathogenesis of Parkinson’s disease

Chi, F., Chen, K., Yin, Y., Hakovirta, J. R., & Saris, P. E. J. (2026) · Sustainable Microbiology · doi:10.1093/sumbio/qvag002 · Cited by 5 · see citing works

Ketogenic diet as a therapeutic strategy for neurodegenerative diseases: from mechanisms to translational challenges

Salgueiro, A. M., Ferreira‐Marques, M., Ribeiro, R. F. N., Lopes, S. M., Pereira, D., Costa, D. G., Santana, M. M., de Almeida, L. P., & Cavadas, C. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00557-1 · Cited by 4 · see citing works

Ketogenic Diets: Answer to Life-Threatening Neurological Diseases

Nanda, M., Pradhan, G., Singh, V., & Barve, K. (2024) · Food and Humanity · doi:10.1016/j.foohum.2024.100364 · Cited by 2 · see citing works

Metabolic Alterations in Human Post‐Mortem Frontal Cortex and Cerebrospinal Fluid Associated With High Levels of Nicotine Metabolite Cotinine

Masvosva, W., Lehtonen, M., Martiskainen, M., Tiihonen, J., Karhunen, P. J., Hanhineva, K., Rysä, J., Kok, E., & Kärkkäinen, O. K. (2025) · Addiction Biology · doi:10.1111/adb.70064 · Cited by 3 · see citing works

Caloric Restriction Alleviates Anxiety-Like Behaviors by Mitigating Neuroinflammation and Insulin Signaling Dysregulation in a High-Fat Diet-Induced Obesity Mouse Model

Xu, Q., Lu, J., Gao, W., Chan, E., Zhang, Y., Huang, K., Xu, A., Wang, X., Sang, K., Gao, X., et al. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.11.013 · Cited by 3 · see citing works

Ketogenic diet in treating sepsis-related acquired weakness: is it friend or foe?

Miao, Y., Xie, L., Chen, S., Zhang, X., Liu, W., & Xie, P. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1484856 · Cited by 5 · see citing works

Gut bacteria composition in animal models of Parkinson’s disease: a systematic review and meta-analysis

Elford, J. D., Heesbeen, E. J., van der Plaats, N. A., Garssen, J., Kraneveld, A. D., Groenink, L., & Perez‐Pardo, P. (2026) · npj Parkinson s Disease · doi:10.1038/s41531-025-01236-0 · Cited by 2 · see citing works

Pink1 at the crossroads of aging, exercise, and diet in Parkinson’s disease: a mechanistic review

Lin, Y., & Wen, D. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1738559 · Cited by 2 · see citing works

Rationale and current status of fecal microbiota transplantations for Parkinson's disease

Bruggeman, A., Vandenbroucke, R. E., & Santens, P. (2026) · Journal of Parkinson s Disease · doi:10.1177/1877718x261455608 · Cited by 2 · see citing works

The Characteristics of the Metabolomic Profile in Patients with Parkinson’s Disease and Vascular Parkinsonism

Predtechenskaya, E. V., Rogachev, A. D., & Melnikova, P. M. (2024) · Acta Naturae · doi:10.32607/actanaturae.27511 · Cited by 2 · see citing works

Replacement of Dietary Carbohydrate with Protein versus Fat Differentially Alters Postprandial Circulating Hormones and Macronutrient Metabolism in Dogs

Jackson, M. I. (2024) · Metabolites · doi:10.3390/metabo14070373 · Cited by 1 · see citing works

Ketones on the Brain: Can Diet Help Turn the Tables on Parkinson's?—Commentary on Mahajan et al. (2024)

Drumond‐Bock, A. L., & Beckstead, M. J. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70025 · Cited by 1 · see citing works

Electroacupuncture exerts neuroprotective effects and alters gut microbiota in a MPTP-induced mouse model of Parkinson’s disease

Wu, X.-C., Dong, Y.-Y., Ying, Y.-C., Chen, G.-Y., Wang, X., Qian, F. A. N., Yin, P., & Chen, Y. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1702912 · Cited by 1 · see citing works

Potential Synergistic Roles of Ketogenic Diet and Stem Cell Therapy in Parkinson's Disease: A Narrative Review

Sindurakar, P., Gorantla, V. R., & Ponnoth, D. S. (2026) · Cureus · doi:10.7759/cureus.103304 · Cited by 1 · see citing works

Efficacy and safety of fecal microbiota transplantation in Parkinson’s disease: a systematic review and meta-analysis of randomized controlled trials with GRADE assessment

Siam, A. M., Moubarak, E. S., Mahmoud, N.-E., Khelifa, H., Aljalawy, F., Hassan, A. A., Ahmed, N. A. T., Wagdy, M., Heikal, Y., & Abbas, O. (2026) · Neurological Sciences · doi:10.1007/s10072-026-09274-z · Cited by 1 · see citing works

Intestinal flora composition and fecal metabolic phenotype in elderly patients with sleep disorders combined with type 2 diabetes

Yin, Z., Xie, H., Liu, F., Kong, X., Chen, W., Gong, Y., & Ge, W. (2024) · Aging Medicine · doi:10.1002/agm2.12376 · Cited by 1 · see citing works

The ketogenic diet as a treatment paradigm for neurological disease

Jaisil, P., Eid, S., Elzinga, S. E., Koubek, E. J., Meyer, J. D., & Feldman, E. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-820480-1.00148-0 · Cited by 1 · see citing works

Gut Microbiota Modulation in Parkinson’s Disease: Exploring Phytotherapy, Pharmacotherapy, and Precision Interventions

Olalekan, S. O., Okwute, P. G., Osonuga, I. O., Mofolorunso, A. M., Adegbesan, B. O., Ezima, E. N., & Oluwatunase, G. O. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1009908

From Refractory Epilepsy to Neurodegeneration: Emerging Mechanistic and Clinical Insights Into the Ketogenic Diet

Ahire, C. G., Yadav, R., Bhamare, U. U., Kaur, G., & Palkar, M. B. (2026) · The FASEB Journal · doi:10.1096/fj.202503317r

Pre- and post-adult effects of ketogenic diet on reproduction, metabolism, and oxidative stress in Drosophila para bang senseless mutants

Abbigeri, M. B., Thokchom, B., Singh, S. R., Gataraddi, S., & Yarajarla, R. B. (2026) · Journal of Food Science and Technology · doi:10.1007/s13197-026-06781-x

Ketogenic β-hydroxybutyrate-regulated β-hydroxybutyrylation of HSPE1 alleviates neuronal apoptosis in MPTP/MPP + induced Parkinson's disease models

Liu, Y., Wang, M., Shi, S., Zhang, J., Wang, W., & Xiang, J. (2026) · Food & Function · doi:10.1039/d6fo01372d

Formaldehyde directly induces cytotoxicity in human lymphocytes through ROS formation, mitochondrial/lysosomal destruction and oxidative stress; analysis of the protective effects of crocin

Salimi, A., Delavari, H., Elyasi, B., Shirmard, L. R., Adhami, V., Abdollahi, F., & Naderi, M. (2026) · Xenobiotica · doi:10.1080/00498254.2026.2707488

The ketogenic diet in Parkinson’s disease: mechanisms, evidence, and clinical practice

Mula, A., Bai, Y., Wang, Y., Lv, P., & Wang, S. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1918711

Natural products in the management of Parkinson's disease in animal models

Desouky, M. A., Abdelhamid, A. H., Gamal, N. K., Naeem, A. G., Sabry, N. C., Fahmy, S. M., Hanna, D. M. F., & Michel, H. E. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-54032-5.00010-3

Neuroprotective effect of a medium-chain triglyceride ketogenic diet on MPTP-induced Parkinson’s disease mice: a combination of transcriptomics and metabolomics in the substantia nigra and fecal microbiome

Zhang, W., Chen, S., Huang, X., Tong, H., Niu, H., & Lu, L. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01549-0 · Cited by 60 · see citing works

Neuroprotective and Anti-inflammatory Activities of Ketogenic Diet on MPTP-induced Neurotoxicity

Yang, X., & Cheng, B. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9336-y · Cited by 159 · see citing works

Exploring the role of gut microbiota in potential mechanism of ketogenic diet in alleviating Parkinson’s disease symptoms

Luo, X.-M., Luo, J., Zhang, Q., Zeng, L.-Y., Liu, B., & Chi, C. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1678894 · Cited by 1 · see citing works

Neuroprotection of fasting mimicking diet on MPTP-induced Parkinson's disease mice via gut microbiota and metabolites

Zhou, Z.-L., Jia, X.-B., Sun, M.-F., Zhu, Y.-L., Qiao, C.-M., Zhang, B.-P., Zhao, L.-P., Yang, Q., Cui, C., Chen, X., et al. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00719-2 · Cited by 195 · see citing works

Gut microbiota as a potential mechanism besides ketone bodies in Ameliorating Parkinson’s disease symptoms with the ketogenic diet

Luo, J., Luo, J., Zeng, L.-Y., & Chi, C.-L. (2025) · Medical Hypotheses · doi:10.1016/j.mehy.2025.111609 · Cited by 2 · see citing works